Cancer often arises from a combination of multiple genetic changes, each conferring characteristics that predispose cells to cause disease. T-cell acute lymphoblastic leukemia (T-ALL) can result from mutations leading to the overexpression of oncogenic transcription factors, such as LMO2, during cell development in the thymus. LMO2 operates indirectly, binding to other transcription factors to regulate their activity. However, the mechanism of LMO2 action in cancer formation is unknown. McCormack et al. show that LMO2 is constitutively expressed in the thymus and induces stem cell-like properties to previously committed T cells. Its expression expands the time of T-cell self-renewal in mice, predisposing the cells to become leukemic. This mouse model of T-ALL provides insight into how LMO2 functions as an oncogene in human cancer, and should help in identifying therapeutics that target self-renewal properties of leukemia-initiating cells.
Cancer: oncogene induces cell self-renewal Open Access
Cancer: oncogene induces cell self-renewal. Dis Model Mech 8 March 2010; 3 (3-4): 122. doi:
Download citation file:
Advertisement
Cited by
Interviews with Biologists @ 100 conference speakers

Explore our interviews with keynote speakers from the Biologists @ 100 conference, hosted to celebrate our publisher’s 100th anniversary, where we discuss climate change and biodiversity with Hans-Otto Pörtner and Jane Francis, health and disease with Charles Swanton and Sadaf Farooqi, and emerging technologies with Manu Prakash and Jennifer Lippincott-Schwartz.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
History of our journals

As our publisher, The Company of Biologists, turns 100 years old, read about DMM’s history and explore the journey of each of our sister journals: Development, Journal of Cell Science, Journal of Experimental Biology and Biology Open.
Other journals from
The Company of Biologists